Author

Yujeong Na

Observed name: Y.S. Na

Institution: Daewoong Pharmaceutical (South Korea)

Observed institutions: Asan Medical Center, University of Ulsan, Daewoong Pharmaceutical (South Korea)

ORCID: 0009-0008-4507-7438

Observed ORCID: 0009-0008-4507-7438

OpenAlex ID: A5018001659

Analysis of serum protein biomarkers, circulating tumor DNA, and dovitinib activity in patients with tyrosine kinase inhibitor-refractory gastrointestinal stromal tumors

2014 · C. Yoo, M.-H. Ryu, et al. · Annals of Oncology · 35

Synergistic Antiviral Activity of Xanthan Gum and Camostat Against Influenza Virus Infection

2025 · Kyeunghwa Chun, Yujeong Na, et al. · Viruses · 5

Ursodeoxycholic acid may protect from severe acute respiratory syndrome coronavirus 2 Omicron variant by reducing angiotensin‐converting enzyme 2

2024 · Kyungmin Lee, Yujeong Na, et al. · Pharmacology Research & Perspectives · 3

Correction: Chun et al. Synergistic Antiviral Activity of Xanthan Gum and Camostat Against Influenza Virus Infection. Viruses 2025, 17, 301

2025 · Kyeunghwa Chun, Yujeong Na, et al. · Viruses · 2

A Nasal Spray Combining Camostat with a Natural Polysaccharide for the Prevention of Viral Infection via Nasal Mucosal Barrier Formation and Entry Inhibition

2026 · Yujeong Na, Byeongyong Kim, et al. · International Journal of Molecular Sciences · 1

Analysis Of Adverse Drug Reactions In Children

2012 · G.M. Park, J.H. Seo, et al. · Journal of Allergy and Clinical Immunology · 1

Dual-Action Niclosamide–Polysaccharide Nasal Spray for the Early Therapeutic Intervention of Respiratory Viral Infections

2026 · Jongseo Choi, Dongjin Lee, et al. · International Journal of Molecular Sciences

Works count: 7

Citation count: 47

H-index: 3

I10-index: 1